✦ LIBER ✦

Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer

✍ Scribed by Joyce N. Barlin; Fanny Dao; Nadim Bou Zgheib; Sarah E. Ferguson; Paul J. Sabbatini; Martee L. Hensley; Katherine M. Bell-McGuinn; Jason Konner; William P. Tew; Carol Aghajanian; Dennis S. Chi

Book ID: 113964113
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 170 KB
Volume: 125
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.03.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progression-free and overall survival of

Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin is comparable to results from GOG 172

✍ J. Barlin; F. Dao; N. Bou Zgheib; S. Ferguson; P. Sabbatini; M. Hensley; J. Konn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Phase II trial of intraperitoneal cispla

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer

✍ Lisa M. Landrum; Johnny Hyde Jr.; Robert S. Mannel; D. Scott McMeekin; Kathleen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Phase I feasibility study of intraperito

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study

✍ Don S. Dizon; Michael W. Sill; Natalie Gould; Stephen C. Rubin; S. Diane Yamada; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; P.H. Thaker; Paul DiSilvestro; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Parenchymal Splenic Metastasis is an Ind

Parenchymal Splenic Metastasis is an Independent Negative Predictor of Overall Survival in Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer

✍ E. Tanner; K. Long; J. Feffer; M. Leitao; N. Abu-Rustum; R. Barakat; D. Chi; G. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Parenchymal splenic metastasis is an ind

Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube and primary peritoneal cancer

✍ E. Tanner; K. Long; J. Feffer; M. Leitao; N. Abu-Rustum; R. Barakat; D. Chi; G. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 163 KB